MYLAN LABS LTD FDA Approval ANDA 202875

ANDA 202875

MYLAN LABS LTD

FDA Drug Application

Application #202875

Application Sponsors

ANDA 202875MYLAN LABS LTD

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL-280.05MG;0.5MG0NORGESTREL AND ETHINYL ESTRADIOLETHINYL ESTRADIOL; NORGESTREL

FDA Submissions

UNKNOWN; ORIG1AP2017-05-08

Submissions Property Types

ORIG1Null19

CDER Filings

MYLAN LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202875
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NORGESTREL AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; NORGESTREL","strength":"0.05MG;0.5MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/08\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.